Green tea leaf for leiomyoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 May 2022: Trial registered, NCT05364008
  2. 5 Jan 2023: Trial started, NCT05364008

The trials

NCT05364008: FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea

State
Under way
Phase
Phase 3
People
33 taking part
Started
5 Jan 2023
Primary completion
3 Jul 2026
Arms
Green tea extract containing 45% epigallocatechin gallate (EGCG)
Results
None posted
  1. 6 May 2022: Trial registered
  2. 5 Jan 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Green Tea Extract.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.